Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in connection with the transaction. GDS Holdings Limited (the “Company” or “GDSH”) (NASDAQ: GDS; HKEX: 9698), a leading...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Celest Therapeutics in the transaction. Celest Therapeutics (Shanghai) Co. Ltd (“Celest”) announced a collaboration with Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in the transaction. The Longreach Group announced that it had, together with the founder family minority shareholders, completed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represents Michael Li, owner of Range Group, a major investor in the buyer group for this transaction. The Washington Commanders and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Aquaron Acquisition Corp. on the deal. Bestpath (Shanghai) IoT Technology Co., Ltd. (Bestpath), a pioneering hydrogen fuel cell powered vehicle company in China,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sequoia China on the deal. Envision Digital, the leading provider of Artificial Intelligence and Internet of Things (AIoT) software driving...
You must be a Standard 1 Year member to access this content.
YPOG, Held Jaguttis, King & Spalding, KNPZ , Pusch Wahlig and Wilson Sonsini Goodrich & Rosati advised Wallaby Medical on the deal. Skadden, Arps, Slate, Meagher...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised InSilico Medicine on the deal. Ashurst represented Mirae Asset Capital. Hong Kong-based InSilico Medicine, a global leader in end-to-end artificial...
You must be a Standard 1 Year member to access this content.
